Key Results from the CHRONOS Multicentre Retrospective Cohort Study Describing Patient Outcomes in Third-Line Acute Gastrointestinal GvHD

Previous Post

THRASSA, A Multicenter, Open-label Study Evaluating The Safety, Tolerability And Efficacy Of MaaT013 In Ruxolitinib-refractory Or Intolerant Paediatric/ Adolescent Participants With Gastrointestinal Acute Graft-versus-Host Disease